BEIGF
BEONE MEDICINES LTD—+0.00 (—)Prev Close—·MCap—·P/E—·Vol—·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
37
$161.51M
◆
Net Activity
Net Seller
$161.51M
●
Active Insiders
8
last 12 mo
Over the past 12 months, insider activity at BEONE MEDICINES LTD (BEIGF) has been exclusively selling, with 0 insider purchases totaling $0.00 and 37 insider sales totaling $161.51M. The most recent insider transaction was by Lee Chan Henry (SVP, General Counsel), who sold $580.2K worth of shares on Feb 4, 2026. BEONE MEDICINES LTD operates in the Technology sector, within the General industry.
BEIGF Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 4, 2026 | Lee Chan Henry | SVP, General Counsel | Sell | 1,660 | $349.52 | $580.2K | 0 |
| Jan 7, 2026 | Lee Chan Henry | SVP, General Counsel | Sell | 664 | $331.76 | $220.3K | 0 |
| Dec 15, 2025 | OYLER JOHN | Chief Executive Officer | Sell | 100,000 | $306.59 | $30.66M | 0 |
| Dec 10, 2025 | Lee Chan Henry | SVP, General Counsel | Sell | 664 | $321.64 | $213.6K | 0 |
| Nov 26, 2025 | Sanders Corazon (Corsee) D. | Director | Sell | 2,627 | $340.90 | $895.5K | 0 |
| Nov 17, 2025 | Wu Xiaobin | President and COO | Sell | 3,991 | $380.43 | $1.52M | 0 |
| Nov 12, 2025 | Lee Chan Henry | SVP, General Counsel | Sell | 996 | $349.17 | $347.8K | 0 |
| Nov 12, 2025 | Wu Xiaobin | President and COO | Sell | 16,009 | $365.22 | $5.85M | 0 |
| Oct 8, 2025 | Lee Chan Henry | SVP, General Counsel | Sell | 10,671 | $350.40 | $3.74M | 0 |
| Sep 16, 2025 | OYLER JOHN | Chief Executive Officer | Sell | 27,803 | $325.71 | $9.06M | 0 |
| Sep 10, 2025 | Lee Chan Henry | SVP, General Counsel | Sell | 10,006 | $325.53 | $3.26M | 0 |
| Sep 9, 2025 | Wang Lai | Global Head of R&D | Sell | 5,000 | $350.06 | $1.75M | 0 |
| Sep 5, 2025 | Sanders Corazon (Corsee) D. | Director | Sell | 2,665 | $337.00 | $898.1K | 0 |
| Sep 2, 2025 | Ball Titus B. | Principal Accounting Officer | Sell | 122 | $326.76 | $39.9K | 0 |
| Aug 13, 2025 | Lee Chan Henry | SVP, General Counsel | Sell | 11,013 | $300.45 | $3.31M | 0 |
| Aug 13, 2025 | Wu Xiaobin | President and COO | Sell | 89,794 | $304.56 | $27.35M | 0 |
| Aug 1, 2025 | Rosenberg Aaron | Chief Financial Officer | Sell | 1,190 | $290.47 | $345.7K | 0 |
| Jul 30, 2025 | Lee Chan Henry | SVP, General Counsel | Sell | 920 | $304.60 | $280.2K | 0 |
| Jul 29, 2025 | Wang Lai | Global Head of R&D | Sell | 4,300 | $302.65 | $1.30M | 0 |
| Jul 18, 2025 | Wang Lai | Global Head of R&D | Sell | 700 | $300.00 | $210.0K | 0 |
| Jul 9, 2025 | OYLER JOHN | Chief Executive Officer | Sell | 27,802 | $253.38 | $7.04M | 0 |
| Jun 24, 2025 | Wang Xiaodong | Director | Sell | 2,007 | $265.50 | $532.9K | 0 |
| Jun 23, 2025 | OYLER JOHN | Chief Executive Officer | Sell | 3,174 | $261.61 | $830.4K | 0 |
| Jun 23, 2025 | Wang Lai | Global Head of R&D | Sell | 1,028 | $260.00 | $267.3K | 0 |
| Jun 23, 2025 | Wu Xiaobin | President and COO | Sell | 1,363 | $260.00 | $354.4K | 0 |
| Jun 16, 2025 | Lee Chan Henry | SVP, General Counsel | Sell | 422 | $266.50 | $112.5K | 0 |
| Jun 16, 2025 | OYLER JOHN | Chief Executive Officer | Sell | 5,140 | $263.33 | $1.35M | 0 |
| Jun 16, 2025 | Wang Lai | Global Head of R&D | Sell | 1,647 | $262.11 | $431.7K | 0 |
| Jun 16, 2025 | Wu Xiaobin | President and COO | Sell | 2,173 | $261.27 | $567.7K | 0 |
| Jun 10, 2025 | Ball Titus B. | Principal Accounting Officer | Sell | 134 | $258.36 | $34.6K | 0 |
| Jun 10, 2025 | Wang Xiaodong | Director | Sell | 41,760 | $262.82 | $10.98M | 0 |
| Jun 6, 2025 | Lee Chan Henry | SVP, General Counsel | Sell | 700 | $256.11 | $179.3K | 0 |
| Jun 6, 2025 | OYLER JOHN | Chief Executive Officer | Sell | 5,127 | $252.77 | $1.30M | 0 |
| Jun 6, 2025 | Wang Lai | Global Head of R&D | Sell | 1,402 | $252.39 | $353.9K | 0 |
| Jun 6, 2025 | Wu Xiaobin | President and COO | Sell | 1,934 | $253.15 | $489.6K | 0 |
| May 13, 2025 | Wang Xiaodong | Director | Sell | 41,760 | $223.50 | $9.33M | 0 |
| May 9, 2025 | OYLER JOHN | Chief Executive Officer | Sell | 1,990,603 | $17.85 | $35.53M | 0 |
| Apr 14, 2025 | Wang Xiaodong | Director | Sell | 41,760 | $242.66 | $10.13M | 0 |
| Apr 1, 2025 | Wu Xiaobin | President, COO & GM China | Sell | 51,921 | $281.40 | $14.61M | 0 |
| Mar 18, 2025 | Wang Xiaodong | Director | Sell | 41,760 | $261.29 | $10.91M | 0 |
| Mar 10, 2025 | OYLER JOHN | Chief Executive Officer | Sell | 41,210 | $242.67 | $10.00M | 0 |
| Mar 7, 2025 | OYLER JOHN | Chief Executive Officer | Sell | 58,590 | $249.12 | $14.60M | 0 |
| Mar 5, 2025 | OYLER JOHN | Chief Executive Officer | Sell | 40,109 | $259.15 | $10.39M | 0 |
| Mar 5, 2025 | Wu Xiaobin | President, COO & GM China | Sell | 51,921 | $261.59 | $13.58M | 0 |
| Mar 4, 2025 | Wang Xiaodong | Director | Sell | 8,146 | $254.58 | $2.07M | 0 |
| Mar 3, 2025 | OYLER JOHN | Chief Executive Officer | Sell | 101,000 | $244.30 | $24.67M | 0 |
| Feb 27, 2025 | Lee Chan Henry | SVP, General Counsel | Sell | 1,205 | $275.00 | $331.4K | 0 |
| Feb 21, 2025 | Lee Chan Henry | SVP, General Counsel | Sell | 1,202 | $258.04 | $310.2K | 0 |
| Feb 21, 2025 | Wang Lai | Global Head of R&D | Sell | 5,000 | $257.23 | $1.29M | 0 |
| Feb 18, 2025 | Wu Xiaobin | President, COO & GM China | Sell | 51,921 | $240.46 | $12.48M | 0 |
Showing 1–50 of 144
1 / 3
BEIGF Insider Buying Activity
The following table shows recent insider purchases of BEONE MEDICINES LTD (BEIGF) stock reported via SEC Form 4 filings.
No insider buying activity found for BEIGF in the last 12 months.
BEIGF Insider Selling Activity
The following table shows recent insider sales of BEONE MEDICINES LTD (BEIGF) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 4, 2026 | Lee Chan Henry | SVP, General Counsel | Sell | 1,660 | $349.52 | $580.2K | 0 |
| Jan 7, 2026 | Lee Chan Henry | SVP, General Counsel | Sell | 664 | $331.76 | $220.3K | 0 |
| Dec 15, 2025 | OYLER JOHN | Chief Executive Officer | Sell | 100,000 | $306.59 | $30.66M | 0 |
| Dec 10, 2025 | Lee Chan Henry | SVP, General Counsel | Sell | 664 | $321.64 | $213.6K | 0 |
| Nov 26, 2025 | Sanders Corazon (Corsee) D. | Director | Sell | 2,627 | $340.90 | $895.5K | 0 |
| Nov 17, 2025 | Wu Xiaobin | President and COO | Sell | 3,991 | $380.43 | $1.52M | 0 |
| Nov 12, 2025 | Lee Chan Henry | SVP, General Counsel | Sell | 996 | $349.17 | $347.8K | 0 |
| Nov 12, 2025 | Wu Xiaobin | President and COO | Sell | 16,009 | $365.22 | $5.85M | 0 |
| Oct 8, 2025 | Lee Chan Henry | SVP, General Counsel | Sell | 10,671 | $350.40 | $3.74M | 0 |
| Sep 16, 2025 | OYLER JOHN | Chief Executive Officer | Sell | 27,803 | $325.71 | $9.06M | 0 |
| Sep 10, 2025 | Lee Chan Henry | SVP, General Counsel | Sell | 10,006 | $325.53 | $3.26M | 0 |
| Sep 9, 2025 | Wang Lai | Global Head of R&D | Sell | 5,000 | $350.06 | $1.75M | 0 |
| Sep 5, 2025 | Sanders Corazon (Corsee) D. | Director | Sell | 2,665 | $337.00 | $898.1K | 0 |
| Sep 2, 2025 | Ball Titus B. | Principal Accounting Officer | Sell | 122 | $326.76 | $39.9K | 0 |
| Aug 13, 2025 | Lee Chan Henry | SVP, General Counsel | Sell | 11,013 | $300.45 | $3.31M | 0 |
| Aug 13, 2025 | Wu Xiaobin | President and COO | Sell | 89,794 | $304.56 | $27.35M | 0 |
| Aug 1, 2025 | Rosenberg Aaron | Chief Financial Officer | Sell | 1,190 | $290.47 | $345.7K | 0 |
| Jul 30, 2025 | Lee Chan Henry | SVP, General Counsel | Sell | 920 | $304.60 | $280.2K | 0 |
| Jul 29, 2025 | Wang Lai | Global Head of R&D | Sell | 4,300 | $302.65 | $1.30M | 0 |
| Jul 18, 2025 | Wang Lai | Global Head of R&D | Sell | 700 | $300.00 | $210.0K | 0 |
| Jul 9, 2025 | OYLER JOHN | Chief Executive Officer | Sell | 27,802 | $253.38 | $7.04M | 0 |
| Jun 24, 2025 | Wang Xiaodong | Director | Sell | 2,007 | $265.50 | $532.9K | 0 |
| Jun 23, 2025 | OYLER JOHN | Chief Executive Officer | Sell | 3,174 | $261.61 | $830.4K | 0 |
| Jun 23, 2025 | Wang Lai | Global Head of R&D | Sell | 1,028 | $260.00 | $267.3K | 0 |
| Jun 23, 2025 | Wu Xiaobin | President and COO | Sell | 1,363 | $260.00 | $354.4K | 0 |
| Jun 16, 2025 | Lee Chan Henry | SVP, General Counsel | Sell | 422 | $266.50 | $112.5K | 0 |
| Jun 16, 2025 | OYLER JOHN | Chief Executive Officer | Sell | 5,140 | $263.33 | $1.35M | 0 |
| Jun 16, 2025 | Wang Lai | Global Head of R&D | Sell | 1,647 | $262.11 | $431.7K | 0 |
| Jun 16, 2025 | Wu Xiaobin | President and COO | Sell | 2,173 | $261.27 | $567.7K | 0 |
| Jun 10, 2025 | Ball Titus B. | Principal Accounting Officer | Sell | 134 | $258.36 | $34.6K | 0 |
| Jun 10, 2025 | Wang Xiaodong | Director | Sell | 41,760 | $262.82 | $10.98M | 0 |
| Jun 6, 2025 | Lee Chan Henry | SVP, General Counsel | Sell | 700 | $256.11 | $179.3K | 0 |
| Jun 6, 2025 | OYLER JOHN | Chief Executive Officer | Sell | 5,127 | $252.77 | $1.30M | 0 |
| Jun 6, 2025 | Wang Lai | Global Head of R&D | Sell | 1,402 | $252.39 | $353.9K | 0 |
| Jun 6, 2025 | Wu Xiaobin | President and COO | Sell | 1,934 | $253.15 | $489.6K | 0 |
| May 13, 2025 | Wang Xiaodong | Director | Sell | 41,760 | $223.50 | $9.33M | 0 |
| May 9, 2025 | OYLER JOHN | Chief Executive Officer | Sell | 1,990,603 | $17.85 | $35.53M | 0 |
| Apr 14, 2025 | Wang Xiaodong | Director | Sell | 41,760 | $242.66 | $10.13M | 0 |
| Apr 1, 2025 | Wu Xiaobin | President, COO & GM China | Sell | 51,921 | $281.40 | $14.61M | 0 |
| Mar 18, 2025 | Wang Xiaodong | Director | Sell | 41,760 | $261.29 | $10.91M | 0 |
| Mar 10, 2025 | OYLER JOHN | Chief Executive Officer | Sell | 41,210 | $242.67 | $10.00M | 0 |
| Mar 7, 2025 | OYLER JOHN | Chief Executive Officer | Sell | 58,590 | $249.12 | $14.60M | 0 |
| Mar 5, 2025 | OYLER JOHN | Chief Executive Officer | Sell | 40,109 | $259.15 | $10.39M | 0 |
| Mar 5, 2025 | Wu Xiaobin | President, COO & GM China | Sell | 51,921 | $261.59 | $13.58M | 0 |
| Mar 4, 2025 | Wang Xiaodong | Director | Sell | 8,146 | $254.58 | $2.07M | 0 |
| Mar 3, 2025 | OYLER JOHN | Chief Executive Officer | Sell | 101,000 | $244.30 | $24.67M | 0 |
| Feb 27, 2025 | Lee Chan Henry | SVP, General Counsel | Sell | 1,205 | $275.00 | $331.4K | 0 |
| Feb 21, 2025 | Lee Chan Henry | SVP, General Counsel | Sell | 1,202 | $258.04 | $310.2K | 0 |
| Feb 21, 2025 | Wang Lai | Global Head of R&D | Sell | 5,000 | $257.23 | $1.29M | 0 |
| Feb 18, 2025 | Wu Xiaobin | President, COO & GM China | Sell | 51,921 | $240.46 | $12.48M | 0 |
BEIGF Insiders
Similar Stocks to BEIGF
SATA
Strive, Inc. Variable Rate Series A Perpetual Preferred Stock
$99.99+0.00%
$65.96B
BTSGU
BrightSpring Health Services, Inc. Tangible Equity Unit
$158.42-1.55%
$24.31B
VLYPN
Valley National Bancorp 8.250% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series C
$26.15-0.38%
$14.53B
AGNCN
AGNC Investment Corp. Depositary Shares Each Representing a 1/1,000th Interest in a Share of 7 percent Series C Fixed-To-Floating Rate Cumulative Redeemable Preferred Stock
$25.71-0.27%
$8.80B
SLMBP
SLM Corporation Floating-Rate Non-Cumulative Series B
$74.40+0.54%
$6.75B
PFH
Prudential Financial, Inc. 4.125% Junior Subordinated Notes due 2060
$16.91-0.59%
$6.06B
VLYPP
Valley National Bancorp 6.25% Fixed-to-Floating Rate Non-Cumulative Perpetual Preferred Stock, Series A
$25.22+0.08%
$5.49B
BANFP
BancFirst Corporation - BFC Capital Trust II Cumulative Trust Pfd Secs
$26.22-0.98%
$4.18B